Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPD-101 in chronic bronchitis COPD
PACTR202609911768910Phase 2Recruiting
- Sponsor
- Expedition Therapeutics
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of XH-S004 in chronic obstructive pulmonary disease (COPD) and chronic bronchitis (CB) (3 arms), sponsored by Expedition Therapeutics. Started Apr 2026; status: recruiting.
02
Drugs
XH-S004
03
Conditions
chronic obstructive pulmonary disease (COPD)chronic bronchitis (CB)
Beyond the preview
Go deeper on PACTR202609911768910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202609911768910.